Kratom Industry Offers Own Standards As Another Firm Warned About FDA Rules - ResearchAndMarkets.com

DUBLIN--()--The "Kratom Industry Offers Own Standards As Another Firm Warned About FDA Rules" newsletter has been added to ResearchAndMarkets.com's offering.

The kratom industry is facing continued scrutiny as a contract manufacturer recently received a warning letter from the US FDA, coincidentally made public on the same day the published standards for safety from the American Kratom Association were released.

While the FDA warning letter to Avalon Packaging, Inc., a contract manufacturer of kratom, cited issues with manufacturing, including salmonella contamination, the agency refrained referencing its 2017 findings that found kratom constituent ingredients to be opioids and potentially in need of being scheduled as controlled substances by the DEA.

For more information about this newsletter visit https://www.researchandmarkets.com/r/3jfeah

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceutical Manufacturing

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceutical Manufacturing